{
    "clinical_study": {
        "@rank": "63890", 
        "brief_summary": {
            "textblock": "In this study, we studied  lipoprotein abnormalities-related variables as risk factors for\n      the development of cardiovascular disease in patients on renal replacement therapies.We\n      studied 96 dialyzed patients, 62 males and 34 females, on mean age 62.1 years old and 24\n      healthy controls.We concluded that metabolic acidosis activating the inflammation and\n      lipoprotein oxidation influences the dyslipidemia and cardiovascular morbidity of patients\n      on renal replacement therapies.Dialysis adequacy was positively associated to\n      cardioprotective HDL.Peritoneal dialysis holds a better acidosis level and lower oxidized\n      lipids than hemodialysis modalities."
        }, 
        "brief_title": "Dyslipidemia-related Risk Factors in Dialysis", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Chronic Renal Disease", 
            "Cardiovascular Disease", 
            "Dyslipidemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Kidney Diseases", 
                "Kidney Failure, Chronic", 
                "Renal Insufficiency, Chronic", 
                "Dyslipidemias"
            ]
        }, 
        "detailed_description": {
            "textblock": "Blood samples were obtained by venipuncture in the peritoneal dialyzed patients and control\n      group in a twelve hours fasting state.In hemodialyzed patients blood was drawn just before\n      the start of the mean weekly dialysis session also in a twelve hours fasting state from the\n      vascular access.\n\n      All samples were received once at baseline time ( in the start of the study ). Peripheral\n      systolic and diastolic blood pressures were calculated as an average of 10 measurements\n      during a renal replacement treatment month in the starting time of the study.\n\n      Also, electrocardiographic examination, echocardiography and the calculation of\n      ankle-brachial blood pressure index became once in the start of the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  permanent renal replacement therapy more than 6 months and\n\n          -  accurate dry body weight\n\n        Exclusion Criteria:\n\n          -  acute illness,\n\n          -  significant infection,\n\n          -  malignancy,\n\n          -  Kt/V for urea <1.2."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "87 Years", 
            "minimum_age": "24 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "We studied 96 dialyzed patients at Nephrology Department of  \"Laiko, University General\n        Hospital of Athens\" and Renal Unit of \"Diagnostic and Therapeutic Center of Athens Hygeia\n        SA\". 62 males and 34 females participated in this study.The treatment modalities which\n        were applied were : regular haemodialysis (HD, n=34), predilution haemodiafiltration (HDF,\n        n=42) and peritoneal dialysis (PD, n=20)."
            }
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02072837", 
            "org_study_id": "E.S.931/5-12-2006"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "hemodialysis, dyslipidemia, cardiovascular disease", 
        "lastchanged_date": "February 27, 2014", 
        "number_of_groups": "1", 
        "official_title": "Dyslipidemia-related Variables as Risk Factor for Cardiovascular Disease in Patients on the End-stage of Renal Disease", 
        "overall_official": {
            "affiliation": "National & Kapodistrian University of Athens, School of Medicine", 
            "last_name": "Vaia D. Raikou, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Greece: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Associations between dyslipidemia with cardiovascular disease on patients on renal replacement therapy", 
            "safety_issue": "No", 
            "time_frame": "February 2014"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02072837"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National and Kapodistrian University of Athens", 
            "investigator_full_name": "Vaia D.Raikou", 
            "investigator_title": "Ph.D Nephrologist; Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "National and Kapodistrian University of Athens", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National and Kapodistrian University of Athens", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}